Societal monetary benefits of pharmaceutical innovation: the case of ramipril in Canada.

Objectives: To estimate the monetary benefits of ramipril and its distribution over time among four beneficiaries in Canada: the drug developing manufacturer, generic manufacturers, the healthcare sector and employment sectors.

Publication Type: Journal Articles

Year of Publication: 2013

Topics: Pharmaceuticals

Authors: Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs

ISSN: 1759-8885

Journal Title: Journal of Pharmaceutical Health Services Research

Volume: 4

Issue: 4

Pages: 195-201